SAN DIEGO, Sept.

NEW YORK, Nov. 30, 2010 /PRNewswire/ -- Regenicin, Inc.

SAO PAULO, May 13, /PRNewswire-FirstCall/ -- Companhia de Concessoes Rodoviarias (CCR) (BM&FBOVESPA: CCRO3), Brazil's largest road concession operator in terms of revenue, announces its results for the 1st quarter 2010. Unless otherwise stated, all financial and operating data herein are presented on a consolidated basis in Reais (R$) pursuant to Brazilian Corporate Law and all comparisons refer to 1Q09. The results of Controlar were included into CCR as of August 13, 2009.

SAO PAULO, Aug.

Celgene International Sarl (Nasdaq:CELG) today announced results from a sub-analysis of a previously reported large, randomized phase III study (AZA-001), which showed that treatment with VIDAZA (azacitidine) prolonged overall survival for patients with high-risk myelodysplastic syndromes (MDS) when compared to conventional care regimens (CCR).